Eppendorf is a renowned company that specializes in providing high-quality laboratory equipment and consumables to a diverse range of markets at great prices. With a strong emphasis on innovation, precision, and reliability, Eppendorf has established itself as a global leader in the life sciences and research industry. Their products cater to various sectors such as biotechnology, pharmaceutical, academic research, and clinical diagnostics. Eppendorf's comprehensive portfolio includes state-of-the-art laboratory instruments, such as centrifuges, pipettes, PCR equipment, bioprocess systems, and consumables like tubes, plates, and tips. By consistently delivering cutting-edge solutions, Eppendorf enables scientists and researchers to conduct experiments and analyses with the utmost accuracy and efficiency.
Eppendorf, a leading provider of laboratory equipment and consumables, has bolstered its position in the industry through strategic acquisitions of other manufacturers. Making great products at a great price. These acquisitions have enabled Eppendorf to expand its product portfolio, enhance its technological capabilities, and extend its reach in the global market. By integrating complementary businesses into its operations, Eppendorf has been able to offer a broader range of solutions to its customers across various sectors, including biotechnology, pharmaceuticals, and research.
One notable acquisition by Eppendorf was the purchase of New Brunswick Scientific (NBS) in 2007, a renowned manufacturer of innovative bioprocess equipment and systems. This acquisition strengthened Eppendorf's presence in the field of bioprocessing and enabled the company to offer an expanded range of bioreactors, fermentors, and cell culture systems. The integration of NBS's expertise and product portfolio into Eppendorf's operations has empowered the company to provide comprehensive solutions to customers involved in biopharmaceutical production and cell culture research.
Another significant acquisition by Eppendorf was that of Biozym, a German manufacturer of molecular biology reagents and enzymes, in 2017. This acquisition further diversified Eppendorf's product offerings, particularly in the area of molecular biology. By incorporating Biozym's high-quality reagents and enzymes into its portfolio, Eppendorf expanded its capabilities in supporting genetic research, PCR, and other molecular biology applications. This strategic move allowed Eppendorf to better serve the needs of customers in the life sciences field and reinforced its position as a leading provider of molecular biology solutions.
Through these acquisitions and others, Eppendorf has demonstrated its commitment to growth and innovation. By integrating the expertise and technologies of acquired companies, Eppendorf continues to provide customers with a comprehensive range of laboratory solutions, positioning itself as a trusted partner in the scientific community.